Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials

doi:10.3748/wjg.v20.i47.17976

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 47

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6289)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

364

WORD

228

HTML

2882

Figures (1-2)

201

Tables (1-5)

191

Sum=3866

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1123

Download

1300

Sum=2423

Dec 21, 2014 (publication date) through Jul 31, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 21, 2014; 20(47): 17976-17984
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17976

Table 5 Cost-effectiveness analysis of the base case

Parameters	FOLFOX4	XELOX
Whole cost	$34416.92	$30466.45
QALY	3.85	3.79
Cost/effect	$8948.28	$8047.30
ICER	$15016.33	-
Threshold (/QALY)	$17815.4	$17815.4

QALY: Quality adjusted life year; ICER: Incremental cost-effectiveness ratio.

Citation: Wen F, Yao K, Du ZD, He XF, Zhang PF, Tang RL, Li Q. Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials. World J Gastroenterol 2014; 20(47): 17976-17984
URL: https://www.wjgnet.com/1007-9327/full/v20/i47/17976.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i47.17976